Market Overview

JP Morgan Comments on Potential Combination Of Valeant And Zoetis, Remains Overweight VRX and Neutral on ZTS

Related VRX
Benzinga's Bulls & Bears Of The Week: Amazon, Costco, Netflix, Tesla And More
Dear Activists: Buying Stock Can Effect More Change Than Selling It
Weekly CFO Buys Highlight (GuruFocus)
Related ZTS
Earnings Scheduled For February 15, 2018
Analyst: Zoetis Deserves To Trade At A Premium

The bank sees Zoetis as an 'attractive, durable, cash-pay business to Valeant's portfolio' and that a deal would be minimal accretive to EPS in the next 12 months. However, the deal would bring benefits in the longer run by aiding multiple expansion. Synergies remain elusive to those trying to identify them

Latest Ratings for VRX

Mar 2018Deutsche BankUpgradesHoldBuy
Jan 2018Goldman SachsInitiates Coverage OnSell
Dec 2017JP MorganDowngradesNeutralUnderweight

View More Analyst Ratings for VRX
View the Latest Analyst Ratings

Posted-In: Analyst Color Reiteration Analyst Ratings


Related Articles (VRX + ZTS)

View Comments and Join the Discussion!